Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,248 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
All Traumas Are Not Created Equal.
Gebauer S, Moore R, Salas J. Gebauer S, et al. Among authors: moore r. JAMA Pediatr. 2019 Apr 1;173(4):398-399. doi: 10.1001/jamapediatrics.2018.5556. JAMA Pediatr. 2019. PMID: 30776075 No abstract available.
Factors Associated With Receipt of Cognitive-Behavioral Therapy or Prolonged Exposure Therapy Among Individuals With PTSD.
van den Berk Clark C, Moore R, Secrest S, Tuerk P, Norman S, Myers U, Lustman PJ, Schneider FD, Barnes J, Gallamore R, Ovais M, Plurad JA, Scherrer JF. van den Berk Clark C, et al. Among authors: moore r. Psychiatr Serv. 2019 Aug 1;70(8):703-713. doi: 10.1176/appi.ps.201800408. Epub 2019 Apr 23. Psychiatr Serv. 2019. PMID: 31010409 Free PMC article.
In silico predicted compound targeting the IQGAP1-GRD domain selectively inhibits growth of human acute myeloid leukemia.
Sahasrabudhe DM, Liesveld JL, Minhajuddin M, Singh NA, Nath S, Kumar VM, Balys M, Evans AG, Azadniv M, Hansen JN, Becker MW, Sharon A, Thomas VK, Moore RG, Khera MK, Jordan CT, Singh RK. Sahasrabudhe DM, et al. Among authors: moore rg. Sci Rep. 2024 Jun 4;14(1):12868. doi: 10.1038/s41598-024-63392-2. Sci Rep. 2024. PMID: 38834690 Free PMC article.
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial.
Valabrega G, Pothuri B, Oaknin A, Graybill WS, Sánchez AB, McCormick C, Baurain JF, Tinker AV, Denys H, O'Cearbhaill RE, Hietanen S, Moore RG, Knudsen AØ, de La Motte Rouge T, Heitz F, Levy T, York W, Gupta D, Monk BJ, González-Martín A. Valabrega G, et al. Among authors: moore rg. Gynecol Oncol. 2024 Jun 3;187:128-138. doi: 10.1016/j.ygyno.2024.03.009. Online ahead of print. Gynecol Oncol. 2024. PMID: 38833992
8,248 results